drugset / Trial / NCT07437391

Effect of L-Carnitine Supplementation in Preterm Neonates

NCT07437391

Recruiting 160 enrolled Muhammad Aamir Latif
RandomizedParallel-groupOpen-labelTreatment

Summary

The current study is planned to see the effect of L-carnitine supplementation in preterm neonates suffering from RDS among the local population, as there is no such evidence available for the local population and there are conflicting statistics regarding the discharge rate of these neonates.

Timeline

Start
2026-01-01
Primary completion
2026-06-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject L-carnitine Other / unclassified 30 mg/kg